A later study by the same group found that rejection of different tumors that are primarily controlled by CD8+ T cells was correlated with inhibition of tumor-induced angiogenesis likely via an IFNγ-dependent mechanism, suggesting a shared mechanism for tumor rejection by both CD4+ and CD8+ T cells (50). The gene discussed is CD8A; the disease is neoplasm.